Showing results (261-270 of 463) with videos related to

Sort By:
Pageof 47
European Journal of Neurology|August 11, 2019
Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH studyH-P Hartung, R Mallick, V Bril, et al.
British Journal of Clinical Pharmacology|June 30, 2015
4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanesAnne-Joy M de Graan, Alex Sparreboom, Peter de Bruijn, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 24, 2007
Cardiac aldosterone in subjects with hypertrophic cardiomyopathyWenxia Chai, Yvonne Hoedemaekers, Ron H N van Schaik, et al.
JACC. Cardiooncology|March 6, 2023
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-UpMelinda A Pruis, G D Marijn Veerman, H Carlijne Hassing, et al.
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquineAlbert L H J Aarnoudse, Ron H N van Schaik, Jeanne Dieleman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 20, 2022
A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant RecipientsLinda G Franken, Marith I Francke, Louise M Andrews, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patientsBronno van der Holt, Marry M Van den Heuvel-Eibrink, Ron H N Van Schaik, et al.
Journal of Inherited Metabolic Disease|February 22, 2012
The cognitive profile of type 1 Gaucher disease patientsMarieke Biegstraaten, Keith A Wesnes, Cécile Luzy, et al.
British Journal of Clinical Pharmacology|December 16, 2018
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipientsL M Andrews, D A Hesselink, R H N van Schaik, et al.
Pageof 47